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ABSTRACT 
Background: Exercise therapy could potentially modify metabolic risk factors and brain 
physiology alongside improving function post stroke  
Objective: To explore the short term metabolic, brain, cognitive and functional effects of 
exercise following stroke  
Methods: 40 participants (>50years, >6months post-stroke, independently mobile) were 
recruited to a single-blind, parallel, randomised controlled trial of community based exercise 
(19 weeks, 3×week, “exercise” group) or stretching (“control” group). Primary outcome 
measures: glucose control and cerebral blood flow. Secondary outcome measures: 
cardiorespiratory fitness; blood pressure; lipid profile; body composition; cerebral tissue 
atrophy and regional brain metabolism; physical and cognitive function. 
Results: Exercise did not change glucose control (Homeostasis model assessment 1·5 ± 0·8 
to 1·5 ± 0·7 vs. 1·6 ± 0·8 to 1·7 ± 0·7, p=0·97, CI -0·5 to 0·49). Medial temporal lobe tissue 
blood flow increased with exercise (38 ± 8 to 42 ± 10ml/100g/min, p<0.05, CI 9.0 to 0.1) 
without any change in grey matter tissue volume. There was no change in medial temporal 
lobe tissue blood flow in the control group (41 ± 8 to 40 ± 7ml/100g/min, p=0.13, CI -3.6 to 
6.7) but significant grey matter atrophy. Cardiorespiratory fitness, diastolic blood pressure, 
high-density lipoprotein cholesterol, physical function and cognition also improved with 
exercise.  
Conclusion: Exercise therapy improves short-term metabolic, brain, physical and cognitive 
function, without changes in glucose control following stroke. The long-term impact of 
exercise on stroke recurrence, cardiovascular health and disability should now be explored.  
Clinical trial registration: URL: http://www.controlled-trials.com/ISRCTN41026907 Trial 
identifier: ISRCTN41026907 
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Introduction 
Stroke affects 152,000 individuals in the UK per year [1] and is the leading cause of 
adult disability. [2] Approximately a third of individuals with stroke will have another stroke 
[3] and 75% present with cardiac disease. [4] There is a need to develop practical 
interventions that reduce disability levels and prevent stroke recurrence and cardiovascular 
disease.  
Stroke recurrence is influenced by a number of modifiable metabolic risk factors, 
including impaired glucose control, dyslipidaemia, hypertension, obesity, and low 
cardiorespiratory fitness. [5] Metabolic abnormalities promote cellular changes that result in 
the alteration of the structure and function of blood vessels and this damage can, in turn, lead 
to stroke and other vascular dysfunctions such as reduced cerebral blood flow. [6-8] In the 
healthy population increasing physical activity has been shown to be an inexpensive, safe, 
and effective method of improving metabolic risk factors and vascular control with minimal 
side effects.[9, 10] Prospective observational studies in healthy individuals also indicate that 
a physically active lifestyle may be neuroprotective: preventing age-related decline in 
cerebral blood flow, brain atrophy, and cognitive function. [11, 12] Whether exercise can be 
used for similar benefit following stroke, where low levels of physical activity are a particular 
problem, [13] has yet to be fully defined. [14]  
Strong evidence demonstrates structured exercise leads to short and long term 
functional benefits post stroke. [14] What has not been determined is whether exercise 
therapy can be used to improve function, but also to modify metabolic and cerebrovascular 
control in the short term leading to long-term reduction in stroke recurrence and improved 
cardiovascular health. The limited translation of current exercise and stroke research findings 
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into clinical care [15] also highlights a need for the development of feasible exercise 
interventions that can be incorporated into the stroke pathway.  
This pilot randomised controlled trial aims to explore the effects of structured 
community exercise on metabolic risk factors, brain, physical and cognitive function post 
stroke. The primary hypothesis was that structured exercise would improve glucose control 
and brain blood flow. Secondary hypotheses were that structured exercise would improve 
cerebral atrophy/metabolism, cardiorespiratory fitness, blood pressure, lipid profile, body 
composition and clinical outcomes (walking ability, balance, cognition, and quality of life) 
and that exercise would be more effective than a home stretching programme in improving 
metabolic risk factors, cerebral blood flow/atrophy/metabolism and clinical outcomes.  
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Methods  
Study design: Single centre, single-blind, parallel, randomised controlled trial of 
community exercise therapy compared with a stretching control group. The study was 
approved by the County Durham and Tees Valley Research and Ethics Committee. All 
subjects gave informed written consent for the study according to the Declaration of Helsinki. 
The study was conducted from May 2011 to February 2012.  
Participants: Eligible subjects were >50 years; had a stroke (>six months previously); 
able to complete six minute walk test (with/without stick); living at home; completed all NHS 
physiotherapy; and were not already undertaking regular exercise (≥3 x week, moderate 
intensity). Exclusion criteria were: absolute and relative contraindications to exercise testing 
(American Heart Association guidelines);[16] insulin dependent diabetes; neurological 
disorders other than stroke; pain on walking (>5 on visual analogue scale); inability to follow 
two stage commands; cognitive problems (mini mental scale examination <24); untreated 
major depression; contraindications to magnetic resonance imaging. 
Setting: Participants were recruited from stroke services in the North East via referral 
from stroke health professionals or local newspaper advert.  
Structured Exercise Intervention: The intervention was adapted from the Fitness and 
Mobility Exercise programme, [17] (Appendix A) a ‘mixed’ exercise intervention 
incorporating functional movement and previously demonstrated to be effective and feasible 
following stroke. [18, 19] Briefly, community leisure centre classes were run by a 
physiotherapist and physical activity instructor for 19 weeks (3 x week, 45-60 minutes). This 
duration was selected as interventions of a similar length have improved both function [20] 
and glucose control post stroke. [21] To progress the cardiovascular element of the exercise 
programme a heart rate training zone was calculated for participants using the Karvonen 
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formula ((Heart rate reserve *training %)+resting heart rate). [22] Initially participants trained 
at 40-50% of their maximum heart rate measured by a heart rate monitor (Polar, Finland), 
with increasing increments of 10% every four weeks up to 70-80%, as tolerated. 
Strength/balance exercises were progressed by increasing repetitions and loading. 
Control Intervention: The control group completed a matched duration home 
stretching programme. Stretching was chosen as other potential control interventions such as 
yoga or Tai chi can improve metabolic risk factors [23] whereas these benefits have not been 
demonstrated with stretching. Participants were given an instruction booklet and diary to 
record stretches and changes in medication/diet/physical activity and contacted fortnightly to 
check progress.  
Outcomes 
Outcomes were assessed at baseline and within one week post intervention by 
assessors blinded to the study hypotheses and group assignment.  
Glucose control: After a 12 hour fast, glucose and insulin were measured before and 
after a 75g glucose load, as described previously. [24] The Homeostasis Model Assessment 
of Insulin Sensitivity (HOMA) was used to calculate insulin sensitivity at baseline ((fasting 
insulin U/ml *fasting glucose mmol/L)/22.5).[25]  
Grey matter atrophy, cerebral blood flow, and regional metabolism: Magnetic 
resonance imaging was undertaken pre and post intervention to measure cerebral tissue 
atrophy, blood flow, and regional metabolism. This protocol was selected as exercise can 
increase global cerebral blood flow [26] and volume [27] and specifically increase blood flow 
in the dentate gyrus. [28] Imaging was performed using a whole body 3.0T magnetic 
resonance (MR) scanner (Achieva, Philips Medical Systems, Best, Netherlands).  
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Anatomical T1 weighted images were collected (FOV 240 × 180 × 216 mm
3; TR 8.3 
ms; TE 4.6 ms) and were segmented in SPM8 to produce grey and white matter masks from 
which longitudinal changes in brain structure over time were examined using voxel based 
morphometry (VBM). 
Cerebral blood flow (CBF) was measured using arterial spin labelling (FAIR method, 
TE 23 ms, TR 4s, 4×4×6mm3 resolution; FOV 256 × 256 × 84 mm2) with inflow times from 
900ms to 2400ms (300ms steps). The imaging volume was positioned parallel to the anterior 
commissure-posterior commissure line with lower slices covering the hippocampus. 
Perfusion weighted and magnitude images were computed for each inflow time from which 
T1 and proton density maps were derived. The inflow transit delay was computed by fitting 
the perfusion signal versus inflow time to a general kinetic model. CBF was then quantified 
based on perfusion signal, proton density images and transit delay, assuming T1 of the blood 
to be 1550ms and blood brain partition coefficient to be 0.9. Global CBF was measured using 
the grey and white matter masks. Medial temporal lobe grey matter blood flow was assessed 
as it was defined as a region of interest from the volumetric scans. 
Metabolite data (N-acetylaspartate (NAA)/total creatine ratio) were collected from a 
single voxel of 40 × 15 ×10 mm3 covering the dentate gyrus using MR spectroscopy (PRESS; 
TE of 38 ms, TR of 3 s, 128 averages). Spectra were analysed in jMRUI software, using the 
QUEST algorithm. [29]   
Cardiorespiratory fitness: A maximal progressive recumbent bicycle exercise test 
was undertaken following a previously devised protocol. [30] Briefly, expired gases were 
analysed at rest (five minutes) and continuously during the test using a mixing chamber 
methodology (Metalyzer 3B Cortex, Leipzig, Germany). A three minute warm up (20 watts) 
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was followed by 10-watt increments every minute until the patient was unable to pedal at 50 
revolutions per minute or voluntarily terminated the test.  
Resting blood pressure: Resting diastolic (DBP) and systolic blood pressure (SBP) 
was recorded twice using a semi-automated sphygmomanometer after ten minutes sitting.  
Lipid profile: Fasted total cholesterol, triacylglyceride, low density lipoprotein 
cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) were determined pre 
and post intervention. Calculation of LDL was obtained using the Friedewald formula. [31] 
Body composition: Height and weight were measured using a standard rigid 
stadiometer to the nearest 0.1cm and calibrated scales to the nearest 0.2kg (Seca medical 769 
column scale, USA). Body mass index was calculated as kg/m². Body composition was 
measured using air displacement plethysmography (BodPod, Life Measurement Inc., CA, 
USA). [32]  
Physical and cognitive outcomes: Pre and post intervention assessments were made of 
1) physical performance: six minute walk test; [33] ten metre walk test [34] and Berg Balance 
Scale, [35] 2) cognitive function: Addenbrooke’s Cognitive Examination Revised (ACE-R), 
[36] and 3) quality of life: Stroke Impact Scale Version 2.0 (SIS). [37] 
Feasibility assessment: Protocol feasibility criteria were: compliance to the study 
protocol (≥90%); attrition rate (≤10%); clinical safety (100%) and effective data processing 
(100%). Ratings used to define study feasibility were: (1) protocol feasible (all success 
criteria achieved); (2) protocol feasible with minor modifications (≥75% success criteria 
achieved); (3) protocol feasible with major modifications (≥50% success criteria achieved) 
and (4) protocol not feasible (none of success criteria achieved). [38] 
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Safety outcomes: Exercise testing followed ACSM safety guidelines. [39] Trial safety 
reporting was undertaken in line with national guidelines. [40]  
Sample size: For cerebral blood flow (CBF) sample size calculation was based on our 
previous CBF measurements which showed intra-subject reproducibility of 8.5%. Effect size 
was postulated at 10%, which is a conservative estimate compared to animal data showing 
the effect of exercise in the mouse. [28] This data indicate that the method has >95% power 
to detect a 10% change in CBF at significance of p=0.01 using pairwise measurements in a 
group of 16 subjects. [41, 42] Sample size was increased to 20 subjects to allow for 20% 
dropout. The sample size for metabolic control was determined from the published data on 
the effect of aerobic exercise upon metabolic control following stroke. [21] Based on changes 
in basal insulin (delta 23 ± 35 vs. -9 ± 42) and 5% confidence level, a sample size of 20 gives 
>80% power. To provide sufficient power to explore both primary outcomes we recruited 20 
patients into the intervention and 20 into the control group.  
Randomisation: A computerised random number generator was used to allocate 
treatment by an independent administrator after screening. After establishing participant 
eligibility and consent the administrator was telephoned for the next number in the sequence 
to enable participant randomisation.  
Statistical methods: Data were inspected for outliers and assessed for normality of 
distribution. Groups were compared at baseline using an independent sample t-test if data 
conformed to the assumptions of normality; if not the independent samples Mann Whitney-U 
test was applied. Between and within group differences were assessed from change scores 
compared using independent sample t-tests. Pre- and post-intervention within group analyses 
were performed using a paired t-test if data conformed to the assumptions of normality, if not 
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the Wilcoxon signed rank test was applied. Statistical significance was indicated if p<0·05. 
Data are presented as means ± SD unless otherwise indicated.  
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Results 
Participant flow: Participants were recruited from two local stroke services over a six-
month period. Four hundred possible participants were screened (see Figure 1 for participant 
flow) to recruit forty participants.   
Participant characteristics: Of the 40 participants 34 were male and 37 had an 
ischaemic stroke. Impairment levels were mild to moderate (National Institute for Health 
Stroke Scale range 0-8) with 55% of participants not achieving age and gender related 
distances on the six minute walk test. There were no significant differences in baseline 
measures between the exercise and control group (Table 1). 
To test the primary and secondary hypotheses within and between group differences 
were investigated for all outcomes: 
Primary outcomes 
The effects of structured exercise on glucose control 
Glucose control: Baseline fasted glucose levels in both groups were normal 
(<7·8mmol/l) (Table 2). At baseline six individuals (3 exercise/3 control) had impaired 
glucose tolerance (IGT) (>7·8 - <11·1mmol/l), and three (1 exercise/2 control) had newly 
diagnosed Type 2 diabetes (T2DM) (>11·1mmol/l). Neither a within or between group 
difference was demonstrated post intervention in two-hour glucose or baseline insulin 
sensitivity (HOMA) (Table 2). Two of the three exercisers starting with IGT changed to 
within normal limits and the individual with T2DM changed to IGT. One of the three controls 
with IGT changed to within normal limits and the two with T2DM changed to IGT. 
The effects of exercise on cerebral blood flow  
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Cerebral Blood Flow: There was no change in global grey matter CBF post 
intervention (Table 2). Regional analysis of medial temporal lobe CBF in the areas seen to 
suffer structural change (Figure 3: clusters 1 and 2) revealed a paired group increase in flow 
following exercise (38± 8 vs. 42 ± 10 ml/min/100g, p=0·05), but not in controls (41 ± 8 vs. 
40 ± 7 ml/min/100g, p=0·27). A between group difference in regional CBF was not observed. 
Secondary outcomes 
Cerebral tissue volume: Paired regional analysis revealed a significant bilateral 
atrophy of the medial temporal lobe in the control group that was not observed in the exercise 
group (Figure 3). A between group difference was not observed in cerebral tissue volume. 
Cerebral metabolism: Good quality MR Spectroscopy data were available in 16 
exercisers and 15 controls due to the technical challenges of acquiring spectroscopy in the 
dentate gyrus. Analysis of the spectra of the ratio of N-Acetylaspartate to creatine (NAA/Cre) 
demonstrated no change following the intervention (Table 2). 
Cardiorespiratory fitness: Significant within group changes were demonstrated with 
exercise in peak oxygen consumption (increased by 17%) and work rate (Table 2, Figure 2, 
Panel A). There were significant between group differences in peak oxygen consumption and 
peak work rate in favour of the exercise group (Table 2).  
Blood pressure: A significant within group increase was demonstrated in diastolic BP 
in the control group (Table 2). There was a significant between group difference in resting 
diastolic but not systolic BP in favour of exercise (Table 2, Figure 2, Panel B).  
Lipid profile: A significant within group improvement in high density lipoprotein 
cholesterol (HDL-C) was observed with exerciser. (Table 2) HDL-C levels increased 
significantly in the exercise group compared to controls (Table 2, Figure 2, Panel C). Total 
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cholesterol and low density lipoprotein cholesterol (LDL-C) levels were unchanged in both 
groups following the intervention (Table 2).  
Body composition: Body mass index and composition were unchanged in both groups 
following the intervention (Table 2). 
The effects of exercise on clinical outcomes  
Significant within group improvements were observed in both groups in measures of 
walking and balance. Significant within group improvements were only made in the exercise 
group in cognition and stroke recovery, mood, strength and overall physical activity. 
Significant between group differences were demonstrated in favour of the exercise 
intervention in walking ability, balance, cognition, mood and overall stroke recovery (Table 
3). 
Protocol feasibility  
The trial protocol was deemed feasible as all the criteria defined for success were 
achieved. 100% (20/20) of the participants in the exercise group completed the intervention 
undertaking >90% of the outcome assessments and exercise sessions. No serious adverse 
events or adverse events were reported over the course of the trial, indicating interventions 
were safe and the exercise protocol was delivered at the right intensity. Participants 
randomised to the exercise intervention group completed an average of 53 hours out of a 
possible 57 hours exercise.  
 
  
15 
 
Discussion 
This pilot study demonstrated for the first time that community based exercise therapy 
is a feasible short-term method of modifying metabolic risk factors and maintaining cerebral 
tissue volume in the medial temporal lobe, alongside improving physical function, cognition 
and some aspects of quality of life, independent of changes in glucose control.  
In contrast to our original hypothesis and data published previously by another group, 
[21] exercise did not have a significant effect on glucose control at a group level. It should be 
noted, however, that only 23% were defined as having Type 2 diabetes or Impaired Glucose 
Tolerance following an oral glucose tolerance test in the present group, compared with 50% 
in the previous study. [21] It is possible that the apparent stability in glucose control 
following exercise reflects the number of study participants who already had adequate 
glucose control, rather than a lack of effect of exercise therapy on glucose regulation. Indeed, 
of the four with impaired glucose control in the exercise group, three made clinically 
significant changes in glucose control. Independent of glucose control, however, there 
remains significant benefits of structured exercise to people living with stroke, which will 
now be discussed. 
Analysis of the brain imaging data revealed significant atrophy of the medial temporal 
lobe in the control group over the 19 week study. In comparison, medial temporal lobe tissue 
structure was maintained and regional blood flow was increased following exercise. Memory 
loss and brain atrophy occur with age. [27] Age related losses in brain volume are, however, 
not uniform and interestingly the medial temporal lobe is one of the areas where significant 
age related loss occurs. [43] and it is also an area that plays a vital role in cognition.[44] The 
fact volume was maintained in this area with exercise and regional blood flow increased, and 
the changes in cognition observed may indicate exercise is a possible means of ameliorating 
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age-related atrophy post stroke and improving long term cognition. The only other study to 
observe the effect of exercise on cerebral blood flow after stroke reports the impact of 
treadmill training upon cerebral blood flow assessed by transcranial Doppler and noted 
improvements in vasomotor reactivity. [45] Our findings extend this work by using a 
quantitative direct measure of cerebral blood flow with regional analysis. Our results 
demonstrate promising exercise related changes in blood flow and cerebral atrophy, and 
although differences noted were within group rather than between group, these novel 
promising findings warrant further exploration in larger better powered studies.  
Exercise produced significant short-term improvements in cardiorespiratory fitness, 
lipid profile and blood pressure. Cardiorespiratory fitness increased by 17% (3ml/kg/min) 
following exercise. Although this improvement may appear small, increasing 
cardiorespiratory fitness by 3ml/kg/min could potentially enable individuals with stroke to 
sustain light activities of daily living (requiring approximately 10.5ml/kg/min) and undertake 
more vigorous activities like fast walking/jogging (requiring approximately 21 ml/kg/min). 
[46]  
Exercise resulted in a 23% increase (0.3mmol/L) in HDL-C. A 0.06mmol/L increase 
has been linked to a 6% reduction in coronary heart disease [47]  and as 75% of stroke 
survivors present with cardiac disease [48] this is a finding worthy of further long term 
exploration. Previous stroke studies have demonstrated no change in lipid profile [49] or 
changes in cholesterol and LDL-C, but not HDL-C, with exercise [50]. Our study is unique in 
demonstrating exercise can improve HDL-C post stroke, this improvement may have been 
due to the length of the intervention and warrants further investigation.  
Exercise reduced diastolic blood pressure by 3mmHg, which again could have led to 
reduction in stroke recurrence as a reduction of DBP of 4 mmHg has been shown to reduce 
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the relative risk of recurrent stroke by 28%.[51] Only a small number of previous studies 
have observed the effect of exercise on blood pressure post stroke with variable findings. [50, 
52] A recent systematic review of lifestyle interventions for secondary stroke prevention 
demonstrated lifestyle interventions could potentially reduce blood pressure when combined 
with medication and medical guidelines. [53] The effect on blood pressure should be further 
explored in a larger study as blood pressure is the main driver of vascular risk following 
stroke. [5] 
Exercise led to clinically significant improvements in both walking speed (0·3 ± 0·14 m/s) 
and endurance (85 ± 47m), supporting recent findings. [14] Overall cognition, as measured 
by the ACE-R, improved with exercise and this finding was in line with previous 
interventional studies in healthy individuals.[54] Quality of life also increased in terms of 
mood and recovery with promising within group improvements in physical function and 
strength. At present the impact of exercise on quality of life post stroke has yet to be 
determined [55] but the few trials that have explored this area demonstrate exercise can 
potentially improve quality of life particularly in terms of mood and physical functioning. 
[56-58]  
Reviewing all the results it was encouraging to find significant between group differences in 
so many outcomes given the size and the pilot nature of the study. This highlights the 
potential positive impact of this type of exercise intervention post stroke.  
No participants left the exercise intervention or experienced any adverse events and 
participants attended over 90% of the sessions over the 19 weeks. One of the most commonly 
reported barriers to exercise post stroke is transport. [59] Although transport was not 
provided to the intervention, and not all participants had access to a car, the high attendance 
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rates indicate in this instance travel was not a barrier to adherence. Adherence to an exercise 
intervention is a key determinant of its success, so these findings are very encouraging.  
Our study has some limitations. The groups were not matched for contact time with 
the research team, meaning that quality of life measures may have improved due to 
socialisation rather than exercise. As the primary outcome of the trial was based on 
physiological measures not quality of life, an attention matched control group was not 
deemed a primary objective The decision not to have an attention matched control group was 
made to optimise retention, as a matched control group with a similar stretching protocol to 
our own experienced high dropout rates (>40%).[21] The high dropout rates could have 
confounded results so it was decided that adherence with the intervention was more important 
than an attention matched control programme. Although the exercise intervention resulted in 
multiple short-term effects, our sample was relatively small and larger multi-centre studies 
are needed to establish if these changes can be maintained over time and influence stroke 
recurrence and comorbidities. The cohort was predominantly male. The fact women have 
higher pre-stroke disability, are more likely to live alone or in care, and have worse post-
stroke functional [60] may have led to low female recruitment and have implications for 
translating research findings for women into clinical care. Finally, the participants were self-
selected and only had mild-moderate deficit (Median NIHSS 3, range 0-8) which may limit 
extension of these findings to people with more severe deficit. 
Conclusions/Implications 
In conclusion, this randomised controlled pilot trial demonstrates that structured 
community delivered exercise therapy after stroke results in short term improvements in 
metabolism, physical function, cognition and quality of life and promising changes in 
cerebral atrophy/blood flow, independent of changes in glucose control. The study protocol 
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was deemed feasible and larger studies should now be conducted exploring the long term 
effects of structured exercise on stroke recurrence, cardiovascular health and disability.   
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Table 1 Baseline demographics and clinical characteristics. Data are mean ± SD or mean unless otherwise 
stated 
Variables 
Exercise group 
(n=20) 
Control group  
(n=20) 
P value 
Demographics    
Gender M/F 18/2 16/4 0·39 
Age (years) 68 ± 8 70 ± 11 0·49 
Body mass index (kg/m²) 26 ± 4 26 ± 4 0·96 
Smoker/non smoker 1/19 3/17 0·30 
Mini-mental state examination  28 ± 2 29 ± 1 0·52 
Months since stroke(range) 21 ± 34 (6-144) 16 ± 12 (6-43) 0·41 
Stroke Characteristics (No. /%) 
  
 
Cerebral hemisphere 
  
 
      Right 10 (50%) 11 (55%) 0·76 
      Left 9 (45%) 7 (35%) 0·53 
      Bilateral 1 (5%) 2 (10%) 0·56 
Haemorrhagic stroke 1 2 0·56 
Vascular location of lesion    
Cortical 5 (25%) 3 (15%) 0·44 
Subcortical    
     Basal ganglia 4 (20%) 3 (15%) 0·67 
     Cerebellar 2 (10%) 3 (15%) 0·64 
     Brain stem 0 (0%) 1 (5%) 0·32 
     Thalamus 0 (0%) 1 (5%) 0·32 
     Internal capsule 0 (0%) 1 (5%) 0·32 
     Subcortical other 7 (35%) 6 (30%) 0·74 
     Unknown 2 (10%) 2 (10%) 1·0 
Functional Characteristics      
NIHSS score  3 ± 3 (0-8) 2 ± 2 (0-7) 0·58 
Walking speed m/s 1·2 ± 0·4 1·2 ± 0·3 0·96 
6 minute walk distance (m) 428 ± 131 419 ± 127 0·84 
Medication (No. /%)      
Beta blocker 3 (15%) 6 (30%) 0·27 
ACE inhibitor 7 (35%) 11 (55%) 0·21 
Diuretic 5 (25%) 3 (15%) 0·44 
Anti-arrhythmic 7 (35%) 3 (15%) 0·15 
Calcium channel blocker 2 (10%) 4 (20%) 0·39 
Statin 18 (90%) 17 (85%) 0·64 
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Table 2 Metabolic risk factors and cerebral blood flow and spectroscopy outcomes. Data are mean ± SD unless otherwise stated 
Variable          Exercise                 Control                                                              Group x Time 
Baseline 19 weeks Δ  P value Baseline 19 weeks Δ  P value  (95% CI) 
Metabolic Risk Factors          
Peak oxygen consumption (ml/kg/min) 18 ± 5 21 ± 5 3 <·01* 18 ± 5 18 ± 5 0 0·62 <·01* (1·3 to 5·2) 
Peak work rate (Watts) 112 ± 36 121 ± 37 9 <·01* 105 ± 34 101 ± 35 -4 0·13 <·01* (0·1 to 0·3) 
Systolic blood pressure (mmHg) 137 ± 27 143 ± 19 6 0·33 135 ± 13 137 ± 11 2 0·50 0·64 (-10 to 16) 
Diastolic blood pressure (mmHg) 84 ± 10 81 ± 11 -3 0·32 83 ± 11 88 ± 10 5 0·04† 0·04† (-14 to 0·4) 
Total cholesterol (mmol/l) 4·5 ± 1·2 4·7 ± 1·2 0.2 0·47 4·4 ± 0·8 4·2 ± 0·8 -0·2 0·36 0·33 (-0·3 to 0·9) 
LDL-C (mmol/l) 2.5 ± 0·9 2·5 ± 0·9 0 0·75 2·5 ± 0·7 2·4 ± 0·7 -0·1 0·96 0·79 (-0·5 to 0·6) 
HDL-C (mmol/l) 1·3 ± 0·4 1·6 ± 0·6 0.3 <·01* 1·4 ± 0·4 1·4 ± 0·3 0 0·76 0·01† (0·05 to 0·4) 
HOMA index 1·5 ± 0·8 1·5 ± 0·7 0 0·99 1·6 ± 0.8 1·7 ± 0.7 0·1 1·0 0·97 (-0·5 to 0·49) 
Two hour glucose (mmol/l) 7 ± 2·7 6·4 ± 1·7 -0.6 0·17 6·8 ± 2·6 6·5 ± 2·2 -0·3 0·53 0·63 (-1·7 to 1·1) 
Body mass index (kg/m²) 26 ± 4 26 ± 4 0 0·06 26 ± 3 26 ± 4 0 0·45 0·25 (-0·7 to 0·2) 
Fat mass (%) 29 ± 9 28 ± 8 -1 0·07 32 ± 7 32 ± 9 0 0·89 0·22 (-3·8 to 0·9) 
Brain Physiology          
Grey matter CBF (ml/100g/min) 34 ± 5 36 ± 14 2 0·39 35 ± 7 33 ± 6 -2 0·32 0·21 (-2·4 to 10·4) 
Medial temporal lobe region CBF 
(ml/100g/min) 
37·6 ± 8 42·2 ± 9·6 4·6 0·05† 41 ± 7·7 39·5 ± 7·2 -1·5 0·27 0·13 (-1·4 to 10·3) 
Dentate gyrus spectroscopy (NAA/Cr) 0·95 ± 0·34 1·01 ± 0·23 0·06 0·67 0·93 ± 0·28 0·98 ± 0·23 0·05 0·55 0·64 (-0·23 to 0·38) 
Figure legend *p<0·01, †p<0·05; LDL-C-low density lipoprotein cholesterol; HDL-C-high density lipoprotein cholesterol; HOMA-homeostasis model of insulin 
sensitivity; CBF-cerebral blood flow; NAA/Cr-N-acetlyaspartate/creatine; Group x Time- between group difference, CI-confidence interval.  
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Table 3 Clinical outcomes-walking ability, balance, cognition, and quality of life. Data are mean ± SD unless otherwise stated. 
Variable                         Exercise                                                                          Control  Group x Time 
Baseline 19 weeks Δ P-value Baseline 19 weeks Δ  P-value  (95% CI) 
Physical Function          
Six minute walk test (m) 428 ± 131 513 ± 131 85 <·01* 419 ± 127 441 ± 126 22 0·02† <0·01* (42 to 86) 
Walking speed (m/s) 1·2 ± 0·4 1·5 ± 0·3 0·3 <·01* 1·2 ± 0·3 1·3 ± 0·3 0·1 0·04† <0·01* (0·1 to 0·3) 
Berg Balance Scale 50 ± 4 55 ± 2 5 <·01* 50 ± 5·6 52 ± 5 2 0·04† <0·01* (0·9 to 5) 
Cognition          
ACE-R 86 ± 8 92 ± 5 6 <·01* 89 ± 6 91 ± 8 2 0·19 0·04† (0·29 to 7·8) 
Quality of Life Stroke Impact Scale          
Stroke recovery 66 ± 28 79 ± 22 13 <·01* 79 ± 22 82 ± 17 3 0·1 0.05† (0·3 to 21) 
Mood 77 ± 24 87 ± 12 10 0·02† 85 ± 19 84 ± 18 -1 0·60 0·02† (2·2 to 20) 
Strength 74 ± 27 79 ± 23 5 0·04† 78 ± 21 83 ± 18 5 0·23 0·77 (-8 to 10) 
Memory 85 ± 19 85 ± 18 0 0·81 87 ± 19 90 ± 13 3 0·52 0·64 (-9·9 to 6) 
Communication 87 ± 21 88 ± 19 1 0·70 96 ± 6 95 ± 6 -1 0·76 0·62 (-6 to 9) 
Activities of daily living 82 ± 19 85 ± 25 3 0·42 90 ± 17 90 ± 15 0 0·75 0·39 (-3 to 8) 
Community mobility 86 ± 25 91 ± 19 5 0·08 90 ± 16 91 ± 12 1 0·40 0·26 (-3 to 10) 
Hand 66 ± 42 69 ± 42 3 0·13 78 ± 31 85 ± 28 7 0·07 0·42 (-11 to 4·9) 
Participation 72 ± 29 76 ± 28 4 0·53 89 ± 18 89 ± 18 0 0·17 0·31 (-7 to 21) 
Physical total 308 ± 92 324 ± 96 16 0·03† 336 ± 78 348 ± 64 12 0·10 0·67 (-15 to 24) 
Figure legend- *P<0·01, †p<0·05, ACE-R-Addenbrooke’s Cognitive Examination-Revised; Group x Time-between group difference, CI-confidence interval
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Appendix A Exercise intervention 
Component Description Duration/Repetitions/Intensity 
Warm up  Slow marching 
 Slow marching with arm swing 
 Knee circle 
 Ankle circles 
Five minutes/Low intensity 
Stretching  Trunk side stretch and rotation  
 Gastrocnemius  
 Quadriceps 
 Gluteus maximus 
 Hamstring. 
Five minutes/ Three stretches on 
each side 
Functional strengthening  Heel-toe raises 
 Chair push-ups 
 Sit-to-stand  
 Sit-to-stand and walking around 
chair 
 Wall push-ups 
 Squat with a gym ball 
15 minutes/ Start with two sets of 
five increase to three sets of ten, 
variable speed 
Balance  Forward reach 
 Heel to toe standing and walking 
 Walking and change direction 
 Standing on one leg 
 Hip flexion, abduction and 
extension 
15 minutes 
Agility and fitness  Forward, side and box step onto a 
step  
 Walking forwards (if able 
progress to gentle jogging) 
 Walking backwards 
 Side stepping 
 Fast marching 
 Step touch 
 Box step 
 Hamstring curl 
15 minutes/Start with five minutes 
of exercise gradually increase to 15 
minutes/Perceived exertion should 
be 4-5 out of 10 on Borg scale 
(fairly light to somewhat hard)/ To 
increase intensity add hand 
weights, increase the height of the 
step. 
Cool down  Combination of warm up and 
stretches 
Five minutes/Low intensity 
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Figure 3  SPM glass brain view and co-ordinates of specific grey matter atrophy in the 
control group after the intervention 
 
 
 
 
 
 
 
 
 
 
Figure legend: Within group comparison showed significant bilateral atrophy of medial 
temporal lobe in the control group (p<0·05) while the exercise group showed no significant 
changes. Data are thresholded at p<0·001 (uncorrected) and applying a minimum cluster size 
(k>10). Coordinates of the significant differences are: 
Region 
Number 
 x y z Cluster 
T 
Voxels 
1 Parahippocampal gyrus Right 28 -8 -18 5·90 85 
2 Parahippocampal gyrus Left -18 -14 -18 4·91 56 
3 Lingual gyrus Right 2 -72 -2 4·42 42 
4 Inferior putamen Right 30 10 -8 4·23 26 
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